A Compassionate Use (CU) Program of Odronextamab
Sponsor: Regeneron Pharmaceuticals
Expanded Access
Sponsor score: 60
Inactive
ClinicalTrials ID:NCT05619367
This compassionate use program provides access to odronextamab, a drug intervention, for patients who meet specific eligibility criteria. The program is designed for individuals with serious or life-threatening conditions who have exhausted other treatment options. Participants must adhere to the outlined medical and safety requirements to qualify for this compassionate use initiative.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
Provide compassionate use of odronextamab
Eligibility Criteria
Get This Program In Your Inbox
You can sign up and apply your patients for this program.
